What is it for?

Retatrutide is the world's first triple receptor agonist — GIP, GLP-1, and glucagon, all in one molecule. Phase 2 data came back at 24% body weight reduction in 48 weeks, which is the highest number any compound has ever produced in clinical trials. The glucagon component is what sets it apart: it actively increases your metabolic rate and drives the liver to burn stored fat. If tirzepatide was two engines, retatrutide is three — and the clinical results reflect it.

💉 Dosing Protocol

Start at 1mg weekly for 4 weeks, then escalate through 2mg, 4mg, 8mg, up to 12mg weekly based on response. Subcutaneous injection.

💡 The triple mechanism

GLP-1 handles appetite suppression. GIP amplifies metabolic signaling. Glucagon raises basal metabolic rate and drives hepatic fat oxidation. Three distinct pathways pulling in the same direction.

📦 Product Details

• Storage: Store lyophilized at 2–8°C. Reconstituted solution stable for 28 days refrigerated.
• Specs: Lyophilized powder, ≥98% purity (HPLC verified). Each order contains 10 vials.